| Product Code: ETC13326126 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Image-Guided Biopsy Market was valued at USD 1.4 Billion in 2024 and is expected to reach USD 2.05 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).
The Global Image-Guided Biopsy Market is experiencing steady growth due to the rising prevalence of cancer and other chronic diseases requiring accurate diagnosis. Image-guided biopsy procedures allow for precise tissue sampling, reducing the need for invasive surgeries and providing real-time feedback to clinicians. Technological advancements in imaging modalities such as MRI, CT scans, and ultrasound have improved the accuracy and efficiency of biopsy procedures, driving market expansion. Additionally, increasing awareness about the benefits of early cancer detection and the growing demand for minimally invasive diagnostic techniques are further propelling market growth. Key players in the market are focusing on developing innovative biopsy devices and expanding their product portfolios to cater to the increasing demand for image-guided biopsy procedures worldwide.
The Global Image-Guided Biopsy Market is experiencing steady growth driven by technological advancements in imaging modalities such as MRI, CT, and ultrasound, leading to improved accuracy and efficiency in biopsy procedures. There is a growing demand for minimally invasive procedures, increasing the adoption of image-guided biopsies over traditional methods. Additionally, the rising prevalence of cancer and other chronic diseases is fueling the demand for early and accurate diagnosis, further propelling market growth. Opportunities lie in the development of advanced imaging technologies, expansion into emerging markets, and collaborations between healthcare providers and technology companies to enhance diagnostic capabilities. The market is poised for continued growth, with key players focusing on innovation and strategic partnerships to capitalize on the increasing demand for image-guided biopsy procedures globally.
The Global Image-Guided Biopsy Market faces several challenges, including the high cost associated with imaging equipment and biopsy procedures, limited accessibility to advanced imaging technologies in certain regions, and the need for specialized training for healthcare professionals to perform image-guided biopsies accurately. Additionally, there are concerns regarding the accuracy and reliability of image-guided biopsy results, as well as potential risks of complications associated with the procedure. Furthermore, regulatory hurdles and reimbursement issues in healthcare systems can pose obstacles to the widespread adoption of image-guided biopsies. Overcoming these challenges will require innovation in technology, increased education and training programs, improved access to advanced imaging facilities, and collaboration among healthcare providers, regulatory bodies, and industry stakeholders.
The global image-guided biopsy market is being driven by several key factors, including the rising prevalence of cancer and other chronic diseases, which necessitate the need for early and accurate diagnosis. Technological advancements in imaging modalities such as MRI, CT, and ultrasound have improved the precision and success rates of biopsies, driving the market growth. Additionally, increasing awareness about the benefits of early detection and minimally invasive procedures among patients and healthcare providers is boosting the demand for image-guided biopsies. Moreover, the growing geriatric population, advancements in personalized medicine, and the increasing adoption of biopsy procedures in developing countries are further propelling the market expansion. Overall, these factors are contributing to the rapid growth of the global image-guided biopsy market.
Government policies related to the Global Image-Guided Biopsy Market primarily focus on regulatory approval processes, quality standards, and reimbursement policies. Regulatory agencies, such as the FDA in the United States and the European Medicines Agency in Europe, play a crucial role in ensuring the safety and efficacy of image-guided biopsy devices. These agencies require manufacturers to adhere to strict guidelines and undergo rigorous testing before products can enter the market. Additionally, government healthcare reimbursement policies influence the adoption of image-guided biopsy procedures by healthcare providers. Reimbursement rates and coverage criteria vary by country, impacting the accessibility and utilization of these technologies. Overall, government policies aim to promote innovation, patient safety, and cost-effectiveness in the Global Image-Guided Biopsy Market.
The Global Image-Guided Biopsy Market is expected to witness significant growth in the coming years, driven by technological advancements in imaging modalities, increasing prevalence of cancer and other chronic diseases, and growing demand for minimally invasive procedures. The market is likely to expand as healthcare facilities adopt image-guided biopsy techniques for accurate diagnosis and treatment planning. Additionally, the rising geriatric population and investments in healthcare infrastructure in emerging economies are anticipated to contribute to market growth. Companies operating in the image-guided biopsy sector are focusing on product innovation and strategic collaborations to gain a competitive edge. Overall, the market is poised for steady expansion, with a growing emphasis on personalized medicine and early disease detection fueling demand for image-guided biopsy procedures.
In the global Image-Guided Biopsy market, Asia Pacific is expected to witness significant growth driven by increasing healthcare infrastructure development and rising adoption of advanced medical technologies in countries like China and India. North America is anticipated to dominate the market due to the presence of well-established healthcare facilities and high healthcare expenditure. Europe is projected to follow closely behind with a strong focus on research and development activities in the healthcare sector. The Middle East and Africa region is likely to experience steady growth with improving access to healthcare services. Latin America is also poised for growth with increasing awareness about early disease detection and improving healthcare infrastructure in countries like Brazil and Mexico.
Global Image-Guided Biopsy Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Image-Guided Biopsy Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Image-Guided Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Global Image-Guided Biopsy Market - Industry Life Cycle |
3.4 Global Image-Guided Biopsy Market - Porter's Five Forces |
3.5 Global Image-Guided Biopsy Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Image-Guided Biopsy Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Global Image-Guided Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Image-Guided Biopsy Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Image-Guided Biopsy Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.10 Global Image-Guided Biopsy Market Revenues & Volume Share, By Biopsy Type, 2021 & 2031F |
4 Global Image-Guided Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Image-Guided Biopsy Market Trends |
6 Global Image-Guided Biopsy Market, 2021 - 2031 |
6.1 Global Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Image-Guided Biopsy Market, Revenues & Volume, By MRI-Guided Biopsy, 2021 - 2031 |
6.1.3 Global Image-Guided Biopsy Market, Revenues & Volume, By CT-Guided Biopsy, 2021 - 2031 |
6.1.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Ultrasound-Guided Biopsy, 2021 - 2031 |
6.1.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Fluoroscopy-Guided Biopsy, 2021 - 2031 |
6.1.6 Global Image-Guided Biopsy Market, Revenues & Volume, By PET-CT Hybrid Imaging Biopsy, 2021 - 2031 |
6.2 Global Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Image-Guided Biopsy Market, Revenues & Volume, By Breast Cancer Diagnosis, 2021 - 2031 |
6.2.3 Global Image-Guided Biopsy Market, Revenues & Volume, By Lung Cancer Detection, 2021 - 2031 |
6.2.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Liver Disease Diagnosis, 2021 - 2031 |
6.2.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Prostate Cancer Screening, 2021 - 2031 |
6.2.6 Global Image-Guided Biopsy Market, Revenues & Volume, By Brain Tumor Assessment, 2021 - 2031 |
6.3 Global Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Image-Guided Biopsy Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Image-Guided Biopsy Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Ambulatory Centers, 2021 - 2031 |
6.3.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.6 Global Image-Guided Biopsy Market, Revenues & Volume, By Academic Medical Centers, 2021 - 2031 |
6.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Image-Guided Biopsy Market, Revenues & Volume, By Direct Procurement, 2021 - 2031 |
6.4.3 Global Image-Guided Biopsy Market, Revenues & Volume, By Distributors, 2021 - 2031 |
6.4.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Online Sales, 2021 - 2031 |
6.4.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Bulk Buyers, 2021 - 2031 |
6.4.6 Global Image-Guided Biopsy Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Image-Guided Biopsy Market, Revenues & Volume, By Fine Needle Aspiration, 2021 - 2031 |
6.5.3 Global Image-Guided Biopsy Market, Revenues & Volume, By Core Needle Biopsy, 2021 - 2031 |
6.5.4 Global Image-Guided Biopsy Market, Revenues & Volume, By Stereotactic Biopsy, 2021 - 2031 |
6.5.5 Global Image-Guided Biopsy Market, Revenues & Volume, By Endoscopic Biopsy, 2021 - 2031 |
6.5.6 Global Image-Guided Biopsy Market, Revenues & Volume, By Incisional Biopsy, 2021 - 2031 |
7 North America Image-Guided Biopsy Market, Overview & Analysis |
7.1 North America Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
7.2 North America Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4 North America Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
7.7 North America Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
8 Latin America (LATAM) Image-Guided Biopsy Market, Overview & Analysis |
8.1 Latin America (LATAM) Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
8.4 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
8.7 Latin America (LATAM) Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
9 Asia Image-Guided Biopsy Market, Overview & Analysis |
9.1 Asia Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
9.4 Asia Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
9.7 Asia Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
10 Africa Image-Guided Biopsy Market, Overview & Analysis |
10.1 Africa Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
10.4 Africa Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
10.7 Africa Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
11 Europe Image-Guided Biopsy Market, Overview & Analysis |
11.1 Europe Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
11.4 Europe Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
11.7 Europe Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
12 Middle East Image-Guided Biopsy Market, Overview & Analysis |
12.1 Middle East Image-Guided Biopsy Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Image-Guided Biopsy Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Image-Guided Biopsy Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Image-Guided Biopsy Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
12.4 Middle East Image-Guided Biopsy Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Image-Guided Biopsy Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Image-Guided Biopsy Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
12.7 Middle East Image-Guided Biopsy Market, Revenues & Volume, By Biopsy Type, 2021 - 2031 |
13 Global Image-Guided Biopsy Market Key Performance Indicators |
14 Global Image-Guided Biopsy Market - Export/Import By Countries Assessment |
15 Global Image-Guided Biopsy Market - Opportunity Assessment |
15.1 Global Image-Guided Biopsy Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Image-Guided Biopsy Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
15.3 Global Image-Guided Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Image-Guided Biopsy Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Image-Guided Biopsy Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
15.6 Global Image-Guided Biopsy Market Opportunity Assessment, By Biopsy Type, 2021 & 2031F |
16 Global Image-Guided Biopsy Market - Competitive Landscape |
16.1 Global Image-Guided Biopsy Market Revenue Share, By Companies, 2024 |
16.2 Global Image-Guided Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here